Medical Management of Microscopic Colitis
Publication Date: January 1, 2016
Last Updated: December 16, 2022
Treatment
Summary of Recommendations of the AGA Guideline on the Medical Management of Microscopic Colitis
In patients with symptomatic microscopic colitis, the AGA recommends treatment with budesonide over no treatment for the induction of clinical remission. ( Moderate , Strong )
612
In patients with symptomatic microscopic colitis, the AGA recommends treatment with budesonide over mesalamine for the induction of clinical remission. ( High , Strong )
612
In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, the AGA suggests treatment with mesalamine over no treatment for the induction of clinical remission. ( Moderate , Conditional (weak) )
612
In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, the AGA suggests treatment with bismuth salicylate over no treatment for the induction of clinical remission. ( Low , Conditional (weak) )
612
In patients with symptomatic microscopic colitis in whom budesonide therapy is not feasible, the AGA suggests treatment with prednisolone (or prednisone) over no treatment for the induction of clinical remission. ( Very Low , Conditional (weak) )
612
In patients with symptomatic microscopic colitis, the AGA suggests against combination therapy with cholestyramine and mesalamine over mesalamine alone for the induction of clinical remission. ( Low , Conditional (weak) )
612
In patients with symptomatic microscopic colitis, the AGA suggests against treatment with Boswellia serrata over no treatment for the induction of clinical remission. ( Low , Conditional (weak) )
612
In patients with symptomatic microscopic colitis, the AGA suggests against treatment with probiotics over no treatment for the induction of clinical remission. ( Low , Conditional (weak) )
612
For patients with recurrence of symptoms following discontinuation of induction therapy for microscopic colitis, the AGA recommends budesonide for maintenance of clinical remission. ( Moderate , Strong )
612
Recommendation Grading
Overview
Title
Medical Management of Microscopic Colitis
Authoring Organization
American Gastroenterological Association
Publication Month/Year
January 1, 2016
Last Updated Month/Year
March 27, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Inclusion Criteria
Adolescent, Adult, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D046728 - Colitis, Microscopic
Keywords
diarrhea, microscopic colitis